(Q28201389)

English

Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention

scientific article (publication date: June 2001)

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11401897%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11401897%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

0 references

0 references

Julio A Ramirez

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11401897%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

American Thoracic Society

19

object named as

American Thoracic Society

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11401897%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

author name string

M S Niederman

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11401897%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

L A Mandell

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11401897%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

A Anzueto

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11401897%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

J B Bass

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11401897%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

W A Broughton

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11401897%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

G D Campbell

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11401897%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

T File

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11401897%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

M J Fine

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11401897%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

P A Gross

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11401897%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

F Martinez

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11401897%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

T J Marrie

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11401897%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

J F Plouffe

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11401897%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

G A Sarosi

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11401897%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

A Torres

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11401897%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

R Wilson

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11401897%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

V L Yu

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11401897%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

N Dean

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11401897%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

language of work or name

0 references

publication date

1 June 2001

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11401897%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

American Journal of Respiratory and Critical Care Medicine

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11401897%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

163

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11401897%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1730-1754

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11401897%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11401897%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Epidemiology of community-acquired respiratory tract infections in adults. Incidence, etiology, and impact

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

The cost of treating community-acquired pneumonia.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Community-acquired pneumonia requiring hospitalization: 5-year prospective study

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Prospective study of the aetiology and outcome of pneumonia in the community

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Severe Community-acquired Pneumonia: Epidemiology and Prognostic Factors

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Severe community-acquired pneumonia. Etiology, prognosis, and treatment

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Etiology of community-acquired pneumonia in out-patients

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Community-acquired pneumonia: impact of immune status

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Severe community-acquired pneumonia. Risk factors and follow-up epidemiology.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Community-acquired pneumonia in the elderly. Clinical and nutritional aspects

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Severe community-acquired pneumonia in the elderly: epidemiology and prognosis. Study Group for Severe Community-Acquired Pneumonia

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

The epidemiology of community-acquired pneumonia among hospitalized adults

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Clinical picture of community-acquired Chlamydia pneumoniae pneumonia requiring hospital treatment: a comparison between chlamydial and pneumococcal pneumonia

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Aetiology of community acquired pneumonia in Valencia, Spain: a multicentre prospective study.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Chlamydia pneumoniae as a cause of community-acquired pneumonia in hospitalized patients in Berlin

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Bacteremia with Streptococcus pneumoniae. Implications for therapy and prevention. Franklin County Pneumonia Study Group

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Effects of cigarette smoking on lung function in adolescent boys and girls.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Bacterial infection in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Re-evaluation of pneumonia requiring admission to an intensive care unit: a prospective study

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Severe community-acquired pneumonia. Assessment of severity criteria

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Diagnostic testing for community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Is Streptococcus pneumoniae the leading cause of pneumonia of unknown etiology? A microbiologic study of lung aspirates in consecutive patients with community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Implications for macrolide treatment in community-acquired pneumonia. Hopkins CAP Team

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Penicillin resistance and other predictors of mortality in pneumococcal bacteremia in a population with high human immunodeficiency virus seroprevalence

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

The drug-resistant pneumococcus: clinical relevance, therapy, and prevention

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Drug-resistant Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population-based study.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Community-acquired pneumonia in old age: a prospective study of 91 patients admitted from home

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

A prediction rule to identify low-risk patients with community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

High-resolution computed tomography for the diagnosis of community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Quality of care, process, and outcomes in elderly patients with pneumonia

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Predicting death in patients hospitalized for community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Community acquired pneumonia: aetiology and usefulness of severity criteria on admission

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Diagnosis of Legionella pneumophila, Mycoplasma pneumoniae, or Chlamydia pneumoniae lower respiratory infection using the polymerase chain reaction on a single throat swab specimen

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Reevaluation of the definition of Legionnaires' disease: use of the urinary antigen assay. Community Based Pneumonia Incidence Study Group.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Bacterial pneumonia associated with HIV-1 infection

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Bacteremic hemophilus influenzae pneumonia in adults. A report of 24 cases and a review of the literature

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Comparative clinical and laboratory features of legionella with pneumococcal and mycoplasma pneumonias

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Prediction of microbial aetiology at admission to hospital for pneumonia from the presenting clinical features. British Thoracic Society Pneumonia Research Subcommittee

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

A Prospective Study of Community-Acquired Pneumonia in Hong Kong

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

A hospital study of community acquired pneumonia in the elderly

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Hospitalized pneumonia. Outcomes, treatment patterns, and costs in urban and rural areas

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Use of prognostic scoring and outcome assessment tools in the admission decision for community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Safely increasing the proportion of patients with community-acquired pneumonia treated as outpatients: an interventional trial.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Implementation of admission decision support for community-acquired pneumonia.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Initial microbiologic studies did not affect outcome in adults hospitalized with community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Pneumococcal macrolide resistance--myth or reality?

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Bacteremic pneumonia due to multidrug-resistant pneumococci in 3 patients treated unsuccessfully with azithromycin and successfully with levofloxacin

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Fatal pneumococcal pneumonia attributed to macrolide resistance and azithromycin monotherapy.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Antibiotics for pneumonia therapy

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Efficacy of a three day course of azithromycin in moderately severe community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Pneumococcal bacteremia in adults: age-dependent differences in presentation and in outcome

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Early switch from intravenous to oral antibiotics in hospitalized patients with bacteremic community-acquired Streptococcus pneumoniae pneumonia

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Evaluation of a pneumonia practice guideline in an interventional trial

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

The clinical benefit of in-hospital observation in 'low-risk' pneumonia patients after conversion from parenteral to oral antimicrobial therapy

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Nonresolving pneumonia in steroid-treated patients with obstructive lung disease

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Bacteraemic pneumococcal pneumonia: a continuously evolving disease

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Diagnostic fiberoptic bronchoscopy and protected brush culture in patients with community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

The value of open lung biopsy in immunocompetent patients with community-acquired pneumonia requiring hospitalization

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

A controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk of serious pneumococcal infections.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Improving the use of pneumococcal vaccine through a strategy of hospital-based immunization: a review of its rationale and implications

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Hospital-based pneumococcal immunization. Epidemiologic rationale from the Shenandoah study

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Emerging infections: pandemic influenza

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Clinical effectiveness of influenza vaccination in Manitoba

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Guillain-Barré syndrome in the United States, 1979-1980 and 1980-1981. Lack of an association with influenza vaccination

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Effect of Macrolides as Part of Initial Empiric Therapy on Length of Stay in Patients Hospitalized With Community-Acquired Pneumonia

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Utility of Fiberoptic Bronchoscopy in Nonresolving Pneumonia

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Severe Community-Acquired Pneumonia

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Risk factors for Staphylococcus aureus nosocomial pneumonia in critically ill patients

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.AT1010

21 January 2018

Identifiers

10.1164/AJRCCM.163.7.AT1010

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11401897%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11401897%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28201389&oldid=1458463565"